These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26070662)

  • 21. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.
    Karageorgopoulos DE; Kelesidis T; Kelesidis I; Falagas ME
    J Antimicrob Chemother; 2008 Jul; 62(1):45-55. PubMed ID: 18436554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen.
    Shields RK; Kwak EJ; Potoski BA; Doi Y; Adams-Haduch JM; Silviera FP; Toyoda Y; Pilewski JM; Crespo M; Pasculle AW; Clancy CJ; Nguyen MH
    Diagn Microbiol Infect Dis; 2011 Jun; 70(2):246-52. PubMed ID: 21353436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. isolates that cause bacteremia and urinary tract infections in Korea.
    Park YK; Lee GH; Baek JY; Chung DR; Peck KR; Song JH; Ko KS
    Microb Drug Resist; 2010 Jun; 16(2):143-9. PubMed ID: 20370437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug resistance among Acinetobacter baumannii isolates from Iran: changes in antimicrobial susceptibility patterns and genotypic profile.
    Bahador A; Raoofian R; Taheri M; Pourakbari B; Hashemizadeh Z; Hashemi FB
    Microb Drug Resist; 2014 Dec; 20(6):632-40. PubMed ID: 25029126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.
    Ko KS; Suh JY; Kwon KT; Jung SI; Park KH; Kang CI; Chung DR; Peck KR; Song JH
    J Antimicrob Chemother; 2007 Nov; 60(5):1163-7. PubMed ID: 17761499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confronting multidrug-resistant Acinetobacter baumannii: a review.
    Neonakis IK; Spandidos DA; Petinaki E
    Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates.
    Kiratisin P; Apisarnthanarak A; Kaewdaeng S
    Int J Antimicrob Agents; 2010 Sep; 36(3):243-6. PubMed ID: 20541913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
    Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
    J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of tigecycline as a therapeutic option against multidrug-resistant Acinetobacter spp.
    Eser OK; Ergin A; Tunçkanat F; Hasçelik G
    New Microbiol; 2008 Oct; 31(4):535-42. PubMed ID: 19123310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
    Agodi A; Voulgari E; Barchitta M; Quattrocchi A; Bellocchi P; Poulou A; Santangelo C; Castiglione G; Giaquinta L; Romeo MA; Vrioni G; Tsakris A
    J Hosp Infect; 2014 Apr; 86(4):260-6. PubMed ID: 24680473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot Screening to Determine Antimicrobial Synergies in a Multidrug-Resistant Bacterial Strain Library.
    Kim SH; Park C; Chun HS; Lee DG; Choi JK; Lee HJ; Cho SY; Park SH; Choi SM; Choi JH; Yoo JH
    Microb Drug Resist; 2016 Jul; 22(5):372-8. PubMed ID: 26974861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
    Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
    Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibiotic resistance patterns in Acinetobacter spp. strains isolated from hospital environment].
    Văduva DB; Muntean D; Lonescu G; Licker M; Văduva MB; Velimirovici D; Rădulescu M; Dumitraşcu V; Crăciunescu M; Dugăeşescu D; Horhat F; Piluţ C; Bădiţoiu L; Moldovan R
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(2):103-7. PubMed ID: 19856849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiology and clinical features of Acinetobacter baumannii infections in humans].
    Wisplinghoff H; Seifert H
    Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):447-57. PubMed ID: 25872254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
    Tognim MC; Andrade SS; Silbert S; Gales AC; Jones RN; Sader HS
    Int J Infect Dis; 2004 Sep; 8(5):284-91. PubMed ID: 15325597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
    Principe L; Capone A; Mazzarelli A; D'Arezzo S; Bordi E; Di Caro A; Petrosillo N
    Microb Drug Resist; 2013 Oct; 19(5):407-14. PubMed ID: 23659601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of extensive drug resistant Acinetobacter baumannii (XDRAB) at Security Forces Hospital (SFH) in Kingdom of Saudi Arabia (KSA).
    Al-Obeid S; Jabri L; Al-Agamy M; Al-Omari A; Shibl A
    J Chemother; 2015 Jun; 27(3):156-62. PubMed ID: 25867622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.